Cutler Group’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,620
Closed -$86.9K 4138
2023
Q3
$88K Buy
10,620
+10,500
+8,750% +$120K 0.01% 1193
2023
Q2
$1K Buy
120
+11
+10% +$134 ﹤0.01% 3362
2023
Q1
$1K Sell
109
-14,802
-99% -$147K ﹤0.01% 3509
2022
Q4
$121K Buy
14,911
+2,274
+18% +$19.6K 0.01% 1060
2022
Q3
$73K Sell
12,637
-289
-2% -$1.66K 0.01% 1619
2022
Q2
$57K Buy
12,926
+1,392
+12% +$8.46K ﹤0.01% 1853
2022
Q1
$104K Buy
11,534
+1,520
+15% +$17.5K 0.01% 1677
2021
Q4
$204K Buy
+10,014
New +$242K 0.01% 1301
2021
Q3
Sell
-2,000
Closed -$59.3K 6192
2021
Q2
$69K Sell
2,000
-36,504
-95% -$1.06M ﹤0.01% 2210
2021
Q1
$1.28M Buy
38,504
+38,404
+38,404% +$1.34M 0.06% 344
2020
Q4
$2K Buy
+100
New +$1.7K ﹤0.01% 4217
2017
Q3
Sell
-12,598
Closed -$44K 6474
2017
Q2
$44K Buy
12,598
+7,127
+130% +$28.7K ﹤0.01% 2631
2017
Q1
$28K Sell
5,471
-8,625
-61% -$42.2K ﹤0.01% 2985
2016
Q4
$53K Sell
14,096
-33,391
-70% -$243K ﹤0.01% 2478
2016
Q3
$425K Sell
47,487
-4,000
-8% -$33.4K 0.02% 687
2016
Q2
$362K Buy
51,487
+37,571
+270% +$343K 0.02% 758
2016
Q1
$118K Buy
13,916
+10,716
+335% +$105K 0.01% 1463
2015
Q4
$42K Buy
+3,200
New +$28.7K ﹤0.01% 2643

Other funds holding PACB